EMMA News and Press, Emmaus Life Sciences Incorporation From 03/31/23

Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif. , March 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a commercial-stage biopharmaceutical company and leader in the treat...

Dr. Niihara Meets with Local Indian Governor PR Newswire Cites Large, Unserved Needs of Sickle Cell Disease Patients TORRANCE, Calif. , Dec. 20, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), announced today that Dr. Yutaka Niiha...

Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari® PR Newswire Celebrity Event Hosted in Mumbai, India TORRANCE, Calif. , Dec. 19, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), announced toda...

Endari® Receives Kuwaiti Marketing Authorization PR Newswire Kuwait is Third Gulf Cooperation Council Country to Approve Endari ® TORRANCE Calif. , Dec. 7, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: E...

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Qatar Ministry of Public Health PR Newswire Company Receives First Major Purchase Order in Saudi Arabia TORRANCE, Calif. , Nov. 17, 2022 /PRNewswire/ -- Emmaus L...

Emmaus Life Sciences press release ( OTCQX:EMMA ): Q3 GAAP EPS of -$0.01. Revenue of $4.94M (-14.4% Y/Y). For further details see: Emmaus Life Sciences GAAP EPS of -$0.01, revenue of $4.94M

/C O R R E C T I O N -- Emmaus Life Sciences, Inc./ PR Newswire In the news release, Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update, issued 14-Nov-2022 by Emmaus Life Sciences, Inc. over PR Newswire, we are advised by the company ...

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif. , Nov. 14, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a commercial-stage biopharmaceutical company and leader in...

Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari® PR Newswire Nationally Syndicated Radio Programming Will Educate and Support SCD Patients TORRANCE, Calif. , ...

Emmaus Life Sciences press release ( OTCQX:EMMA ): Q2 GAAP EPS of -$0.18. Revenue of $4.3M misses by $1.7M . At June 30, 2022, the company had cash and cash equivalents of $1.0 million For further details see: Emmaus Life Sciences GAAP EPS of -$0.18, revenue ...